Literature DB >> 6223073

Autoimmunity and immune complex disease after neonatal induction of transplantation tolerance in mice.

M Goldman, H M Feng, H Engers, A Hochman, J Louis, P H Lambert.   

Abstract

Mice made neonatally tolerant to alloantigens were found to develop an immunologic disease resembling systemic lupus erythematosus. In BALB/c mice neonatally injected with C57BL/6 X BALB/c F1 hybrid spleen cells, features of autoimmunity were observed first. After 5-24 wk, antinuclear, anti-SS DNA, thymocytotoxic, and rheumatoid factor-like antibodies were detected in association with hypergammaglobulinemia and with the occurrence of circulating immune complexes and cryoglobulins. Some of the antinuclear antibodies were found to be produced by F1 donor B cells persisting in the host. Second, immunopathologic changes were detected in tolerant mice. In the kidneys, an immune complex glomerulonephritis of the membranous type was observed. Immunoglobulin deposits were also found in the choroid plexus and at the dermoepidermal junction. In addition, thrombocytopenia was a common finding, and a positive direct Coomb's test occasionally was detected. Features of autoimmune disease were closely associated with the effective induction of transplantation tolerance, as revealed by the inability of spleen cells to generate in vitro cytolytic responses against C57BL/6 alloantigens. It is suggested that, although transplantation tolerance is associated with a lack of cytolytic reaction of the host against F1 hybrid donor alloantigens, other types of allogeneic interactions could lead in this model to the development of autoimmunity and immunopathology.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6223073

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

Review 1.  Lessons about autoantibody specificity in systemic lupus erythematosus from animal models.

Authors:  D I Stott
Journal:  Clin Exp Immunol       Date:  1990-07       Impact factor: 4.330

2.  Persistence of allospecific helper T cells is required for maintaining autoantibody formation in lupus-like graft-versus-host disease.

Authors:  L Rozendaal; S T Pals; E Gleichmann; C J Melief
Journal:  Clin Exp Immunol       Date:  1990-12       Impact factor: 4.330

3.  Completely allogeneic spleen cells induced cytolytic neonatal tolerance to alloantigens, but failed to establish allo-helper interactions with host T cells.

Authors:  A Ramos; M González; M López-Hoyos; R Carrió; J Merino
Journal:  Immunology       Date:  1996-11       Impact factor: 7.397

4.  Natural thymocytotoxic autoantibodies in non-obese diabetic (NOD) mice: characterization and fine specificity.

Authors:  A Lehuen; J Altman; J F Bach; C Carnaud
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

Review 5.  T cells, murine chronic graft-versus-host disease and autoimmunity.

Authors:  Robert A Eisenberg; Charles S Via
Journal:  J Autoimmun       Date:  2012-06-16       Impact factor: 7.094

Review 6.  T cell subsets in glomerular diseases.

Authors:  S Florquin; M Goldman
Journal:  Springer Semin Immunopathol       Date:  1994

7.  Autoimmune disease after neonatal injection of semi-allogeneic spleen cells in mice: involvement of donor B and T cells and characterization of glomerular deposits.

Authors:  D Abramowicz; M Goldman; C Bruyns; P Lambert; Y Thoua; C Toussaint
Journal:  Clin Exp Immunol       Date:  1987-10       Impact factor: 4.330

8.  Hyperactivity of donor B cells after neonatal induction of lymphoid chimerism in mice.

Authors:  M Goldman; D Abramowicz; P Lambert; P Vandervorst; C Bruyns; C Toussaint
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

9.  Autoimmune disease and malignant lymphoma associated with host-versus-graft disease in mice.

Authors:  M Tateno; N Kondo; T Itoh; T Yoshiki
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

10.  Modulation of murine host-versus-graft disease by anti-CD3 monoclonal antibody.

Authors:  M Wissing; A Marchant; M Moser; V Flamand; O Leo; D Abramowicz; J Urbain; M Goldman
Journal:  Clin Exp Immunol       Date:  1991-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.